Skip to main content
OpenTrials

Clinical trial condition

Febrile Neutropenia

Explore clinical trials studying Febrile Neutropenia. Study availability and eligibility vary by location and protocol.

98 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Febrile Neutropenia trial results

Completed

A Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal Cancer

NCT01619423

Conditions
Advanced Metastatic (Stage IV) Colorectal Cancer, Agranulocytosis, Colonic Diseases, +17 more
Locations
  • Moores UCSD Cancer Center La Jolla, California, United States
  • Center for Cancer and Blood Disorders Bethesda, Maryland, United States
  • Associates in Oncology & Hematology Chattanooga, Tennessee, United States
  • Wellmont Medical Associates Oncology and Hematology Kingsport, Tennessee, United States
View all 33 locations
View Trial Details
Completed

A Post Marketing Surveillance Study of Lipo-AB® (Amphotericin B) in Neutropenic Patients With Persistent Fever

NCT03511820

Conditions
Agranulocytosis, Cytopenia, Febrile Neutropenia, +6 more
Locations
  • Changhua Christian Hospital Changhua, Taiwan
  • Kaohsiung Veterans General Hospital Kaohsiung City, Taiwan
  • Kaohsiung Chang Gung Memorial Hospital Kaohsiung City, Taiwan
  • Keelung Chang Gung Memorial Hospital Keelung, Taiwan
View Trial Details
Completed

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

NCT00911170

Conditions
Agranulocytosis, Body Temperature Changes, Cancer, +28 more
Locations
  • Research Site Muscle Shoals, Alabama, United States
  • Research Site Jonesboro, Arkansas, United States
  • Research Site Anaheim, California, United States
  • Research Site Beverly Hills, California, United States
View all 154 locations
View Trial Details
Completed

Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options

NCT00945555

Conditions
Agranulocytosis, Cytopenia, Febrile Neutropenia, +5 more
Locations
  • Pfizer Investigational Site Kayseri, Turkey, Turkey (Türkiye)
  • Pfizer Investigational Site Kocaeli, Turkey, Turkey (Türkiye)
  • Pfizer Investigational Site Ankara, Turkey (Türkiye)
  • Pfizer Investigational Site Bursa, Turkey (Türkiye)
View Trial Details
Completed

Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer

NCT01569087

Conditions
Agranulocytosis, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • Arkhangelsk District Clinical Oncology Dispensary Arkhangelsk, Russia
  • Perm Region Oncology Dispensary Perm, Russia
  • N.N.Petrov Oncology Research Center Saint Petersburg, Russia
  • Russian scientific center of radiology and surgery technologies Saint Petersburg, Russia
View Trial Details
Completed

Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients

NCT02104830

Conditions
Agranulocytosis, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • Arkhangelsk District Clinical Oncology Dispensary Arkhangelsk, Russia
  • Clinical Hospital at Chelyabinsk Railway Station Chelyabinsk, Russia
  • State public health institution "Republican Clinical Oncology Dispensary" of the Ministry of Health of the Republic of Tatarstan Kazan', Russia
  • Non-governmental healthcare institution "Central Clinical Hospital № 2 Semashko" JSC "Russian Railways" Moscow, Russia
View all 13 locations
View Trial Details
Completed

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

NCT01459653

Conditions
Adnexal Diseases, Agranulocytosis, B-cell Lymphoma, +61 more
Locations
  • Sandoz Investigational Site Innsbruck, Austria
  • Sandoz Investigational Site Kufstein, Austria
  • Sandoz Investigational Site Leoben, Austria
  • Sandoz Investigational Site Deurne, Belgium
View all 117 locations
View Trial Details

Related conditions